2006
DOI: 10.1128/iai.74.2.1025-1031.2006
|View full text |Cite
|
Sign up to set email alerts
|

Correlation of Molecular Characteristics, Isotype, and In Vitro Functional Activity of Human Antipneumococcal Monoclonal Antibodies

Abstract: Structure-function correlations of pneumococcal antibodies are important in predicting how changes in the pneumococcus (Pnc)-specific B-cell repertoire will influence humoral immunity against invasive Pnc disease. Using a unique panel of human hybridomas derived from memory B cells after pneumococcal conjugate vaccination, we analyzed the structure-function relationship of nine monoclonal antibodies (MAbs) reactive to Pnc polysaccharides. The avidities of the antibodies correlated with the avidity of donor imm… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
16
0

Year Published

2009
2009
2014
2014

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(17 citation statements)
references
References 37 publications
(30 reference statements)
1
16
0
Order By: Relevance
“…The requirement for neutrophils, but not complement, when a higher dose of 7A9 was used and the requirement for complement when a lower dose was used suggest there could be a dichotomy between Fc and complement receptors in 7A9-mediated antipneumococcal activity, depending on the amount of antibody. More work is needed to determine whether 7A9-and/or 5F6-like antibodies are produced in response to PPS3 vaccination in humans, but it is worth noting that 5F6-like antibodies would not be identified by the standard opsonophagocytosis assay, because it includes a complement source (5,68). Nonetheless, 5F6-like antibodies might be useful when complement is scarce, as it can be in the setting of pneumococcal infection and sepsis (73).…”
Section: Discussionmentioning
confidence: 99%
“…The requirement for neutrophils, but not complement, when a higher dose of 7A9 was used and the requirement for complement when a lower dose was used suggest there could be a dichotomy between Fc and complement receptors in 7A9-mediated antipneumococcal activity, depending on the amount of antibody. More work is needed to determine whether 7A9-and/or 5F6-like antibodies are produced in response to PPS3 vaccination in humans, but it is worth noting that 5F6-like antibodies would not be identified by the standard opsonophagocytosis assay, because it includes a complement source (5,68). Nonetheless, 5F6-like antibodies might be useful when complement is scarce, as it can be in the setting of pneumococcal infection and sepsis (73).…”
Section: Discussionmentioning
confidence: 99%
“…Although human monoclonal antibodies to S. pneumoniae have been produced in the past (Baxendale and Goldblatt, 2006; Baxendale et al, 2000; Zhou et al, 2002; Zhou et al, 2004), these previous studies have been limited by two factors: one, they employed Fab expression library screens and two, they employed random production of hybridomas. In addition, previous studies have either focused on one serotype (6B and 23F) or have utilized vaccination with the conjugate vaccine Prevnar that consists of only seven capsular serotypes.…”
Section: Introductionmentioning
confidence: 99%
“…The human Ab response to PPS is oligoclonal, and anti-PPS Abs repeatedly use a limited range of V-genes (4,5). Abs against the 23F serotype of S. pneumoniae frequently use IGKV2-24 or IGKV3-11 for the L chain and IGHV3-30 for the H chain (6).…”
mentioning
confidence: 99%